Clinician Perspectives of Chronic Pain Management in Children and Adolescents with Cerebral Palsy and Dyskinesia

Experienced clinicians from interdisciplinary teams participated in this study

- to share their perspectives on the barriers and facilitators to chronic pain management for children and adolescents with cerebral palsy and dyskinesia.

Four themes emerged from the focus groups:

  • balancing the intersec

Read more: Clinician Perspectives of Chronic Pain Management in Children and Adolescents with Cerebral Palsy and Dyskinesia

Does your region or country have any special laws or regulations about children with additional or special needs?

I am thinking of laws that are additional to those for all children

Peter Limbrick writes:

Most countries have laws and regulations about provision for children of school age. But what about babies and infants before they reach school age?

I am interested to learn about governments that have made re

Read more: Does your region or country have any special laws or regulations about children with additional or special needs?

Early Interventionists' Ratings of Family-Centered Practices in Natural Environments - Report

‘research suggests that many early interventionists continue to work directly with the child’

From the website below:

"Part C early intervention services should be family centered and occur in the context of families' natural environments and daily routines; yet research suggests that many early int

Read more: Early Interventionists' Ratings of Family-Centered Practices in Natural Environments - Report

Disability-related stigma and discrimination in sub-Saharan Africa and south Asia: a systematic literature review

By Bhavisha Virendrakumar, Cathy Stephen, Emma Jolley and Elena Schmidt

 

Executive summary - Introduction

Sightsavers is an international non-governmental organisation (INGO) working to eliminate avoidable blindness and promote equal opportunities for people with disabilities. Addressing sti

Read more: Disability-related stigma and discrimination in sub-Saharan Africa and south Asia: a systematic literature review

FDA delays Decision on Moderna vaccine for adolescents citing heart problems, Yet Pfizer authorized for teens, despite higher number of myocarditis reports

By Megan Redshaw

The U.S. Food and Drug Administration (FDA) said on Oct. 15 it was delaying a decision on authorizing Moderna’s COVID vaccine for adolescents while the agency assesses whether the shot could increase the risk of myocarditis, a heart inflammatory condition, the Wall Street Journ

Read more: FDA delays Decision on Moderna vaccine for adolescents citing heart problems, Yet Pfizer authorized for teens, despite higher number of myocarditis reports

share your information  Cartoon © Martina Jirankova-Limbrick 2011